Bang & Olufsen A/S
26.6.2026 15:53:42 CEST | Globenewswire | Press release
Major Shareholder Announcement
Major Shareholder Announcement
Bang & Olufsen A/S has, pursuant to the Danish Capital Markets Act, received a major shareholder notification from UBS Group AG.
- As per 22 June 2026, UBS Group AG’s holding of shares and voting rights pursuant to section 38 of the Danish Capital Markets Act, as well as other financial instruments pursuant to section 39(2), was below 5 percent of the total share capital and voting rights in Bang & Olufsen A/S.
- As per 23 June 2026, UBS Group AG’s holding of shares and voting rights pursuant to section 38 of the Danish Capital Markets Act, as well as other financial instruments pursuant to section 39(2), was above 5 percent of the total share capital and voting rights in Bang & Olufsen A/S.
As of 23 June 2026, UBS Group AG held a total of 7,473,135 shares and voting rights in Bang & Olufsen A/S, corresponding to 5.07 percent of the total share capital and voting rights.
For further information, please contact:
Cristina Rønde Hefting
Sr. Director, Head of Strategy & Investor Relations
Phone: +45 4153 7303
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S15.7.2026 17:50:45 CEST | Press release
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
North Media A/S15.7.2026 15:13:58 CEST | Pressemeddelelse
Svensk pressemeddelelse fra SDR
North Media A/S15.7.2026 15:13:58 CEST | Press release
Swedish press release from SDR
Fluence15.7.2026 15:00:00 CEST | Press release
Fluence Retains Tier 1 Energy Storage Supplier Status in S&P Global Energy 2026 Cleantech List
Persephoni Bio15.7.2026 15:00:00 CEST | Press release
Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom